In cases involving unpredictable factors, such as most chemical reactions, pharmaceutical activity, and physiological ...

China approved AstraZeneca Plc’s blockbuster breast cancer treatment for reimbursement by state-run medical insurance, a move that will boost the British drugmaker’s sales in the country in the midst ...

Sanofi inaugurated its $800m healthcare manufacturing facility, Modulus, located in Tuas Biomedical Park to be operational in ...

The biggest threat for European pharmaceutical groups currently comes from the United States. President-elect Donald Trump ...

Learn about the legal battle between Bristol Myers Squibb and the HHS over the 340B drug pricing program, as other drugmakers join in with rebate plans.

Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be ...

The microbial therapeutic products market is forecast to grow from USD 17.11 billion in 2022 to USD 30.55 billion by 2030, ...

A new experimental weight loss drug from Amgen — the first in a growing group of drugs aimed at once-a-month injections instead of once a week — helped patients lose up to 20% of their weight in one ...

Diet is increasingly seen as a modifiable risk factor in prostate cancer. Recent studies have shown that ...

The World Bank’s ‘one stop shop’ bid to up investment. Plus, we list down the Inter-American Development Bank's top 10 ...

Hudson says many CEOs are scared of AI, comparing it to The Terminator’s John Connor traveling back in time to stop the rise ...

Massachusetts Financial Services Co. MA lifted its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 4.8% in the ...